Amivantamab compared with real-world therapies in patients with advanced non-small cell lung cancer EGFR Exon 20 insertion mutations after platinum-based chemotherapy

Author:

Kim Tae Min1,Girard Nicolas2,Low Grace Kah Mun3,Zhuo Jianmin4,Yu Dae Young5,Yang Yishen4,Murota Maiko6,Lim Cindy Thiow Koon7,Kleinman Nora J.8,Cho Byoung Chul9

Affiliation:

1. Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea

2. Institut Curie, Institute du Thorax Curie-Montsouris, Paris, France

3. Medical Affairs, Janssen Asia Pacific Medical Affairs, a division of Johnson & Johnson International (Singapore) Pte. Ltd

4. Statistics and Decision Science, Janssen China Research & Development, China

5. Real World Evidence, Janssen Asia Pacific, Republic of Korea

6. Global Development, Medical Affair Operations, Janssen Research & Development, Tokyo, Japan

7. Real World Solutions, IQVIA Solutions Asia Pte Ltd, Singapore

8. Real World Solutions, IQVIA Hong Kong, Kwai Fong, Hong Kong, P.R. China

9. Department of Medical Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Republic of Korea

Publisher

Medical Journals Sweden AB

Subject

Radiology, Nuclear Medicine and imaging,Oncology,Hematology,General Medicine

Reference43 articles.

1. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

2. Ferlay J Ervik M Lam F et al. Global cancer Observatory: cancer today. Lyon France: International Agency for Research on Cancer 2020. [Internet]. 2020 [cited 2022 Jun 3]. Available from: https://gco.iarc.fr/today/home.

3. Lung cancer: diagnosis and management;Collins LG;afp,2007

4. Lung Cancer Staging and Prognosis

5. The IASLC Lung Cancer Staging Project: External Validation of the Revision of the TNM Stage Groupings in the Eighth Edition of the TNM Classification of Lung Cancer

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3